Home > Specialists > Radiation Oncology > Dr. Zhirui Zhou (周支瑞)
Specialty & Clinical Focus:
Radiation oncologist at Huashan Hospital, Fudan University in Shanghai, with a clinical focus on central nervous system tumors and malignant tumors of the body and head and neck, using IMRT, CyberKnife stereotactic radiotherapy, chemotherapy, and targeted therapy.
Professional Title & Qualifications:
-
Chief Physician
-
Ph.D. in Oncology, Fudan University
Hospital & Department：
Shanghai Huashan Hospital Affiliated to Fudan University – Department of Radiation Oncology
(address: No. 12 Middle Wulumuqi Road, Jing'an District, Shanghai, 200040)
Dr. Zhirui Zhou (周支瑞) - Radiation Oncologist
Personal Biography
Dr. Zhirui Zhou is a Chief Physician in the Department of Radiation Oncology at Huashan Hospital, Fudan University in Shanghai. He holds a Ph.D. in Oncology from Fudan University and has 16 years of clinical experience in radiation therapy for malignant tumors. His clinical work focuses on central nervous system tumors—including brain metastases, glioma, and meningioma—as well as breast, lung, prostate, nasopharyngeal, and other malignant tumors. He is also involved in translational oncology research and applies IMRT, CyberKnife stereotactic radiotherapy, chemotherapy, and targeted therapy within comprehensive treatment pathways.
Why Choose Dr. Zhirui Zhou: Clinical Expertise & Patient Value
Dr. Zhirui Zhou combines 16 years of radiation oncology experience with a Ph.D. in Oncology and translational research at Huashan Hospital, Fudan University. His practice covers complex central nervous system tumors—including gliomas, brain metastases, and meningiomas—as well as malignant tumors of the body and head and neck. This breadth is particularly relevant for international patients seeking specialist review of whether radiotherapy approaches such as IMRT or CyberKnife may form part of a broader multidisciplinary treatment pathway.
For a productive remote specialist review, patients should prepare recent imaging, pathology reports, previous treatment records, current medications, and a concise list of questions. Reviewing these materials before travel allows Dr. Zhou to provide a clearer specialist opinion on potential treatment approaches, information gaps, and practical next steps, helping patients make a better-informed decision about whether to pursue an in-person hospital pathway in Shanghai.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel to Shanghai, international patients can request MedBridgeNZ coordination for a remote specialist review with Dr. Zhirui Zhou. We organize medical-record preparation, translation coordination, client-authorized secure document transfer, and appointment communication with the relevant hospital or specialist office.
Dr. Zhou or the relevant hospital team will review the submitted records and provide a specialist opinion, recommendations, and responses to the patient’s prepared questions. This pre-travel pathway can clarify potential treatment directions, identify any additional records requested by the specialist, and help the patient decide whether to proceed with an in-person hospital appointment and travel arrangements in China.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Zhirui Zhou
Areas of Expertise
Central Nervous System Tumors: Brain Metastases, Glioma, Glioblastoma, Central Nervous System Lymphoma, Meningioma, Intracranial Germ Cell Tumor, Brainstem Tumor, Pituitary Tumor, Ependymoma, Medulloblastoma, Pinealocytoma, etc.
Malignant Tumors of the Body: Bone Metastases, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Laryngeal Cancer, etc.
Therapeutic Methods: Comprehensive treatment of solid tumors including Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Radiotherapy (CyberKnife), Chemotherapy, and Targeted Therapy.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
1,000 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
July 2019 - Present: Attending Physician, Department of Radiation Oncology, Huashan Hospital, Fudan University
July 2017 - June 2019: Resident Physician, Department of Radiation Oncology, Fudan University Shanghai Cancer Center
July 2013 - September 2014: Resident Physician, Department of Radiation Oncology, Jilin Provincial Cancer Hospital
Education & Training
Ph.D. in Oncology, Fudan University
Awards & Honors
Academic & Professional Memberships
Member, Shanghai Medical Association
Member, Youth Committee of the Radiotherapy Professional Committee, Shanghai Anti-Cancer Association
Research & Publications
Dr. Zhou has led or participated in several National Natural Science Foundation of China projects and has published over 50 academic papers in the field of oncology. Additionally, he has edited or co-authored two oncology books and has written numerous medical popular science articles.
Selected Peer-Reviewed Publications
Zhou Z, et al. Optimal treatment strategy for central nervous system non-germinomatous germ cell tumors: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2025;207:104615. PMID: 39814246.
Zhou Z, et al. Optimal treatment approach for intracranial germinoma: a systematic review and meta-analysis. BMC Cancer. 2025;25(1):26. PMID: 39773126.
Kudulaiti N, Zhou Z, et al. A nomogram for individualized prediction of overall survival in patients with newly diagnosed glioblastoma: a real-world retrospective cohort study. BMC Surg. 2021;21(1):238. PMID: 33957923.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Zhou’s radiation oncology expertise relevant to my cancer diagnosis?
Dr. Zhou’s clinical focus includes central nervous system tumors such as brain metastases, glioma, glioblastoma, central nervous system lymphoma, meningioma, and intracranial germ cell tumors, together with breast, lung, prostate, nasopharyngeal, and other malignant tumors. Relevance to an individual case depends on the diagnosis, imaging, pathology, and previous treatment history. MedBridgeNZ coordinates preparation, translation, and client-authorized transfer of these records to the relevant hospital or specialist office, where Dr. Zhou will review them and provide a specialist opinion on the case and potential next steps.
How can an international patient request a remote specialist review with Dr. Zhou?
International patients can submit an enquiry to request remote specialist-review coordination. MedBridgeNZ helps organize the medical records, coordinates translation where needed, transfers the documents securely with the patient’s authorization, and communicates the patient’s key questions to the relevant hospital or specialist office. Dr. Zhou will review the submitted materials and provide his specialist opinion and recommendations. After the review, MedBridgeNZ can assist with appointment-request communication, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support for an in-person visit to Shanghai.
What does Dr. Zhou’s comprehensive treatment approach for central nervous system tumors involve?
Dr. Zhou’s comprehensive approach may include intensity-modulated radiation therapy (IMRT), stereotactic radiotherapy using CyberKnife, chemotherapy, and targeted therapy. The specific approach depends on the tumor type, location, previous treatment, and other case-specific information. A remote specialist review allows Dr. Zhou to examine the submitted records, explain which treatment options may be relevant, identify information that may still be needed, and answer the patient’s prepared questions before any decision is made about travelling to Shanghai for an in-person hospital pathway.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with remote specialist-review coordination, medical-record preparation, translation coordination, client-authorized document transfer, appointment-request communication, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Hospital, specialist, diagnostic, treatment, and travel charges are separate third-party costs unless a specific item is expressly stated in writing as part of a MedBridgeNZ coordination service.